Oluwaseyifunmi Andi Agbejule

Oluwaseyifunmi Andi Agbejule

Auto-generated profile, based on publicly available information

Oluwaseyifunmi Andi Agbejule

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
RCRaymond J. Chan
Raymond J. Chan
Louisa GordonLouisa Gordon
Louisa Gordon
CTChia Jie Tan
Chia Jie Tan
ACAlexandre Chan
Alexandre Chan
NBNatalie Bradford
Natalie Bradford
CMChristine Miaskowski
Christine Miaskowski

23 February 2022 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
OAOluwaseyifunmi Andi Agbejule
Oluwaseyifunmi Andi Agbejule
Nicolas H. HartNicolas H. Hart
Nicolas H. Hart
SEStuart Ekberg
Stuart Ekberg
MCMegan Crichton
Megan Crichton
RCRaymond Javan Chan
Raymond Javan Chan

26 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JJJolyn Johal
Jolyn Johal
CHChad Yixian Han
Chad Yixian Han
RJRia Joseph
Ria Joseph
ZMZachary Munn
Zachary Munn
OAOluwaseyifunmi Andi Agbejule
Oluwaseyifunmi Andi Agbejule
Nicolas H. HartNicolas H. Hart
Nicolas H. Hart
Cancer-associated malnutrition, or cachexia, stemming from cancer or its treatments, is particularly prevalent in metastatic cancers, and is often interrelated with sarcopenia and frailty. Evidence suggests that dietary supplements play a role in managing these conditions. As metastatic cancer cells are associated with notable genomic and phenotypic alterations, response to dietary supplements may differ between metastatic and non-metastatic cancers. However, research in this area is lacking. This scoping review aims to identify the dietary supplements that have been studied in patients with metastatic cancers and malnutrition-related conditions, along with their proposed effects, mechanisms, outcome measures, and tools used. A systematic search was conducted across databases, including MEDLINE, EMBASE, CINAHL, and clinical trial registries. Of the initial 6535 records screened, a total of 48 studies were included, covering a range of dietary supplements—vitamins, minerals, antioxidants, proteins, amino acids, fatty acids, fiber, and others. While the types of dietary supplements included varied across cancer types, omega-3 and carnitine were investigated most often. Proposed relevant attributes of dietary supplements included their antioxidant, anti-inflammatory, anti-cancer, and immunomodulatory properties. Overall, there was a paucity of interventional studies, and more randomized controlled trials are warranted.

9 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
MCMegan Crichton
Megan Crichton
PYPatsy M. Yates
Patsy M. Yates
OAOluwaseyifunmi Andi Agbejule
Oluwaseyifunmi Andi Agbejule
ASAmy Spooner
Amy Spooner
RCRaymond J. Chan
Raymond J. Chan
Nicolas H. HartNicolas H. Hart
Nicolas H. Hart
Non-pharmacological self-management interventions for chemotherapy-induced peripheral neurotherapy (CIPN) are of clinical interest; however, no systematic review has synthesized the evidence for their use in people with advanced cancer. Five databases were searched from inception to February 2022 for randomized controlled trials assessing the effect of non-pharmacological self-management interventions in people with advanced cancer on the incidence and severity of CIPN symptoms and related outcomes compared to any control condition. Data were pooled with meta-analysis. Quality of evidence was appraised using the Revised Cochrane Risk of Bias Tool for Randomized Trials (RoB2), with data synthesized narratively. Grading of Recommendations, Assessment, Development and Evaluations (GRADE) was applied to assess the certainty of the evidence. Thirteen studies were included, which had a high (69%) or unclear (31%) risk of bias. Greatest confidence was found for physical exercise decreasing CIPN severity (SMD: −0.89, 95% CI: −1.37 to −0.41; p = 0.0003; I2 = 0%; n = 2 studies, n = 76 participants; GRADE level: moderate) and increasing physical function (SMD: 0.51, 95% CI: 0.02 to 1.00; p = 0.04; I2 = 42%; n = 3 studies, n = 120; GRADE level: moderate). One study per intervention provided preliminary evidence for the positive effects of glutamine supplementation, an Omega-3 PUFA-enriched drink, and education for symptom self-management via a mobile phone game on CIPN symptoms and related outcomes (GRADE: very low). No serious adverse events were reported. The strongest evidence with the most certainty was found for physical exercise as a safe and viable adjuvant to chemotherapy treatment for the prevention and management of CIPN and related physical function in people with advanced cancer. However, the confidence in the evidence to inform conclusions was mostly very low to moderate. Future well-powered and appropriately designed interventions for clinical trials using validated outcome measures and clearly defined populations and strategies are warranted.

1 September 2020 in Cancer Nursing
Verified
Journal Article
Closed access
RCRaymond J. Chan
Raymond J. Chan
DMDeborah K. PhD Mayer
Deborah K. PhD Mayer
BKBogda Mbioethics Koczwara
Bogda Mbioethics Koczwara
VLVictoria PhD Loerzel
Victoria PhD Loerzel
ACAndreas Charalambous
Andreas Charalambous
DHDoris Howell
Doris Howell

14 July 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
OAOluwaseyifunmi Andi Agbejule
Oluwaseyifunmi Andi Agbejule
NHNicolas H. Hart
Nicolas H. Hart
SEStuart Ekberg
Stuart Ekberg
BKBogda Koczwara
Bogda Koczwara
RLRahul Ladwa
Rahul Ladwa
RCRaymond Javan Chan
Raymond Javan Chan
Background: Cancer-related fatigue (CRF) is one of the most common and distressing symptoms in people with cancer. Although efficacy of interventions for CRF have been extensively investigated, less has been done to ensure successful translation into routine clinical practice. The aim of this systematic scoping review was to synthesise knowledge surrounding the implementation of CRF interventions, summarise the processes and outcomes of implementation strategies used, and identify opportunities for further research. Methods: PubMed, Cochrane CENTRAL, EMBASE and CINAHL databases were searched (up to December 2020). The Cochrane Effective Practice and Organisation of Care (EPOC) Group taxonomy and the RE-AIM Framework were used to guide the evaluation of implementation strategies and outcomes, respectively. Results: Six studies were included. Three used an implementation framework (PARIHS, KTA, Cullens & Adams’ Implementation Guide) to guide implementation. Overall, the implementation strategies used across all studies were reported to have directly resulted in immediate changes at the clinician level (e.g., increased clinician behaviours, self-efficacy, attitudes, knowledge of CRF management). No clear relationship was found between the use of implementation models and the number or type of implementation strategies used. For outcomes, Effectiveness and Implementation were the most highly reported RE-AIM measures followed by Reach then Maintenance. Adoption was the least reported. Conclusions: Despite the high prevalence of CRF and evidence-based interventions for managing CRF, there is limited evidence informing the sustainable implementation of these interventions. This systematic scoping review emphasises the lack of quality CRF implementation studies presently available in the literature leading to a disconnect between effective CRF interventions, routine clinical care, and cancer survivors at present. This review highlights the need for robust study designs guided by established frameworks to methodically design and evaluate the implementation of CRF management interventions in the future.